BRIEF-bluebird bio provides updates on HSC gene therapy programs
* bluebird bio Inc-Lentiglobin drug product manufactured for two patients in HGB-206 and HGB-207 confirms two-to-threefold increase in vector copy numbers
MADRID, April 29 Private equity firm KKR & Co LP has agreed to give Spain's Uralita a 320 million euro ($417 million), seven-year loan, the Spanish firm said in a regulatory filing on Monday.
Uralita, a construction materials manufacturer, said the agreement would allow it to repay its bank creditors and bondholders while providing more time and funds to develop its future plans.
* Forum Energy Technologies announces pricing of public offering of common stock Source text for Eikon: Further company coverage:
* Atkore International Group Inc. announces launch of secondary public offering of common stock